Cell Analysis Market Size, Share, and Industry Analysis, By Offerings (Product {Consumables and Instruments}, Software & Services), By Technique (Flow Cytometry, Cell Imaging, Single-Cell Analysis, and Others), By Application (Research, Disease Diagnostics, and Others), By End-user (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Others), and Regional Forecast till 2032

The global cell analysis market is experiencing substantial growth driven by the increasing usage of cell analysis in disease diagnosis and the development of effective, advanced therapies, as the prevalence of chronic diseases is significantly increasing. The cell analysis plays a crucial role in identifying and characterizing biomarkers associated with chronic diseases, such as cancer and cardiovascular diseases, which enables accurate diagnoses resulting in their higher demand. Additionally, advancements in cell analysis technologies, such as microscopy and single-cell analysis, and the expanding scope of drug discovery and development are expected to drive the market growth.

• For instance, in May 2023, BD (Becton, Dickinson and Company) launched a cell sorting instrument with high-speed cell imaging and technologies such as BD CellView and BD SpectralFX.

Cell analysis is used to study cells, including their number, health, viability, proliferation, and response to various stimuli. It is an important tool in basic research, drug discovery, and clinical applications.

Cell Analysis Market Driver

Increase in Research Activities Through Collaborations & Funding Initiatives to Boost Market Growth

An increase in research activities, due to collaborations and funding initiatives, is expected to boost the call analysis market growth. These research initiatives drive innovation, leading to the development of more advanced and effective cell analysis technologies. Strong research funding and collaborations are expected to accelerate the development and adoption of these technologies, leading to significant market growth.

• For instance, in February 2022, the Chan Zuckerberg Initiative (CZI) granted USD 2 million to teams studying rare inflammatory pediatric diseases. This was aimed at using single-cell biology to understand disease mechanisms, heterogeneity, and improve diagnostics. This initiative highlighted the importance of patient partnership in research.

Single-Cell Analysis-Related Studies (In Percentage), from 2000-2019

According to the data published by the National Center for Biotechnology Information (NCBI), in November 2020, the U.S. gave the highest contribution in the field of single-cell analysis research, followed by China, Germany, and Japan.

Cell Analysis Market Restraint

High Cost of Instrumentation Expected to Hinder Market Growth

The high cost of instrumentation is expected to hinder the market growth during the forecast period. This is due to cell analysis instruments, such as advanced flow cytometers and high-content screening systems, are very expensive, which requires significant capital investment for research facilities and organizations. Thus, the high cost of instrumentation is anticipated to create a barrier for the purchase by smaller companies, further hampering the market growth.

• For instance, according to the data published by Excedr, a company providing lab equipment for life science startups, in January 2024, the price range for the high-end flow cytometer is USD 5,00,000 to USD 10,00,000, for fluorescence-activated cell sorting (FACS) for single-cell analysis research.

Cell Analysis Market Opportunity

Rise in Focus on Single-Cell Analysis Technologies Provides Growth Opportunities in Future

The increasing focus on single-cell analysis technologies provides a significant growth opportunity in the future, especially in areas such as cancer research and drug discovery. This is due to the rise in need for more detailed insights into cellular diversity and heterogeneity. Single-cell analysis offers several key advantages, such as revealing cellular heterogeneity and providing an exact understanding of biological systems. Moreover, single-cell analysis provides insights into the diverse behaviors within cell populations, which is important for the understanding of biological processes and diseases.

Additionally, a rise in approvals and new product launches based on single-cell analysis is expected to increase the market growth in the near future. 

• For instance, in February 2024, Takara Bio USA, Inc. announced its plans to launch two single-cell solutions for oncology research. It includes automated single-cell total RNA-seq and DNA-seq library preparation kits.

Key Insights

The report covers the following key insights:

• Technological Advancements in Cell Analysis
• New Product Launches, By Key Players
• Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.

Segmentation

Analysis by Offerings

By offerings, the market is divided into product {consumables and instruments}, software & services. The product segment is further classified into consumables and instruments. 

The product segment accounted for a significant revenue share in the market. The reagents and consumables are used across various cell analysis techniques, such as flow cytometry, microscopy, etc. Thus, these are the versatile and essential components for research and diagnostics, which drive the segment growth. Additionally, frequent purchasing needs are also expected to boost the market growth.

• For instance, in May 2025, BD launched BD FACSDiscover A8 Cell Analyzer, a cell analyzer with spectral and real-time cell imaging technologies. The spectral technology increases the number of colors used in flow cytometry.

Analysis by Technique

By technique, the market is divided into flow cytometry, cell imaging, single-cell analysis, and others.

The flow cytometry segment is expected to hold a significant share of the cell analysis market. This is due to it has ability to rapidly analyze multiple characteristics such as size, granularity, etc., of individual cells. Additionally, technological advancement and the rise in demand for effective diagnostic tools drive the segment's growth. 

• For instance, the Navios EX flow cytometer, manufactured by Beckman Coulter Life Sciences, has three high-powered solid-state lasers with innovative scatter detection technology, which provides flexibility for microparticle and cell analysis.

Analysis by Application

By application, the market is divided into research, disease diagnostics, and others.

The research segment held a substantial share of the global cell analysis market in 2024. This growth is driven by a rise in investment in drug discovery and biopharmaceutical research. The pharmaceutical companies are continuously developing new drugs and therapies thus, cell analysis is an important tool in this process, which drives the segment's growth. 

• For instance, according to the data published by the National Center for Biotechnology Information, in August 2020, recently single-cell lineage tracing techniques with a combination of transposons or CRISPR/Cas9 genome editing and single-cell transcriptome sequencing have been developed. 

Analysis by End-user

According to the end user segment, the market is classified into pharmaceutical & biotechnology companies, diagnostic laboratories, and others. The pharmaceutical & biotechnology companies segment held a significant portion of the market. This is due to an increase in demand for biopharmaceutical products, which drives the demand for efficient and cost-effective production methods and support the segment growth. Additionally, mergers and acquisitions between key operating players also support the segment's growth.

• For instance, in August 2023, Cell Microsystems acquired Fluxion Biosciences to enhance its cell analysis product and services portfolio. This acquisition adds BioFlux, IonFlux, and IsoFlux products to Cell Microsystems’s portfolio.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

To gain extensive insights into the market, Download for Customization

North America accounted for a substantial share of the global cell analysis market in 2024. The rise in research and development activities in this region, with a strong presence of pharmaceutical and biotechnology industries, drives the market growth in this region. Additionally, new product launches, collaboration, and partnerships between key market players also boost the regional cell analysis market growth.

• For instance, in February 2024, Cell Microsystems entered into a strategic partnership with OMNI Life Science (OLS), aiming to launch three innovative cell analysis products in the U.S. and Canadian markets.

Europe has a significant share of the global cell analysis market. The increasing prevalence of cancer in Europe fuels demand for advanced cell analysis techniques used in diagnostics and drug development, which drives the market growth in this region. Additionally, innovations in cell imaging, flow cytometry, and high-content screening also support the market growth in this region by enabling more efficient and detailed cell analysis.

Asia Pacific is the fastest-growing region during the forecast period. The rise in research activities and the growing pharmaceutical industry support the market growth in this region.

Key Players Covered

The global cell analysis market is fragmented with the presence of several key operating players. The report includes the profiles of the following key players:

• Merck KGaA (Germany)
• Agilent Technologies, Inc. (U.S.)
• Revvity (U.S.)
• BD (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Sartorius AG (Germany)
• Sysmex (Japan)
• Takara Bio Inc. (Japan)

Key Industry Developments

• In February 2024, Singleron opened new offices and labs in Ann Arbor, Michigan, USA, to expand its commercial reach and innovation efforts. The new facility aims to provide a one-stop service for single-cell analysis. 
• In April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., specializes in instruments and consumables for single-cell isolation, detection, and analysis. Celsee's products and technologies increase Bio-Rad's presence in the growing areas of precision medicine and single-cell analysis.